Search research articles
Contact Us
Filters
Showing results (41-50 of 175) with videos related to
Page
of 18
Sort By:
The Journal of Allergy and Clinical Immunology
|
October 28, 2008
Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis
Sébastien Conus, Alex Straumann, Hans-Uwe Simon
Digestive Diseases (Basel, Switzerland)
|
March 8, 2014
Eosinophilic esophagitis and allergy
Dagmar Simon, Alex Straumann, Hans-Uwe Simon
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 24, 2019
Reply
Thomas Greuter, Alain M Schoepfer, Alex Straumann
The New England Journal of Medicine
|
October 15, 2011
Placebo and other interventions in asthma
Alex Straumann, Ekaterina Safroneeva, Alain M Schoepfer
Gastrointestinal Endoscopy Clinics of North America
|
November 14, 2017
Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis
Ekaterina Safroneeva, Alex Straumann, Alain M Schoepfer
Case Reports in Gastroenterology
|
October 29, 2013
Induction of eosinophilic esophagitis by sublingual pollen immunotherapy
Stephan Miehlke, Oral Alpan, Sören Schröder, et al.
Seminars in Immunopathology
|
June 7, 2021
Eosinophilic esophagitis-established facts and new horizons
Luc Biedermann, Alex Straumann, Thomas Greuter, et al.
The Journal of Allergy and Clinical Immunology
|
June 15, 2010
Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis
Sébastien Conus, Alex Straumann, Eva Bettler, et al.
Allergo Journal International
|
November 7, 2017
Current concepts in eosinophilic esophagitis
Dagmar Simon, Alex Straumann, Alain M Schoepfer, et al.
The American Journal of Medicine
|
September 28, 2014
Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis
Jasmin Kahn, Christian Bussmann, Christoph Beglinger, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 175) with videos related to
Sort By:
Page
of 18
The Journal of Allergy and Clinical Immunology
|
October 28, 2008
Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis
Sébastien Conus, Alex Straumann, Hans-Uwe Simon
Digestive Diseases (Basel, Switzerland)
|
March 8, 2014
Eosinophilic esophagitis and allergy
Dagmar Simon, Alex Straumann, Hans-Uwe Simon
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 24, 2019
Reply
Thomas Greuter, Alain M Schoepfer, Alex Straumann
The New England Journal of Medicine
|
October 15, 2011
Placebo and other interventions in asthma
Alex Straumann, Ekaterina Safroneeva, Alain M Schoepfer
Gastrointestinal Endoscopy Clinics of North America
|
November 14, 2017
Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis
Ekaterina Safroneeva, Alex Straumann, Alain M Schoepfer
Case Reports in Gastroenterology
|
October 29, 2013
Induction of eosinophilic esophagitis by sublingual pollen immunotherapy
Stephan Miehlke, Oral Alpan, Sören Schröder, et al.
Seminars in Immunopathology
|
June 7, 2021
Eosinophilic esophagitis-established facts and new horizons
Luc Biedermann, Alex Straumann, Thomas Greuter, et al.
The Journal of Allergy and Clinical Immunology
|
June 15, 2010
Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis
Sébastien Conus, Alex Straumann, Eva Bettler, et al.
Allergo Journal International
|
November 7, 2017
Current concepts in eosinophilic esophagitis
Dagmar Simon, Alex Straumann, Alain M Schoepfer, et al.
The American Journal of Medicine
|
September 28, 2014
Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis
Jasmin Kahn, Christian Bussmann, Christoph Beglinger, et al.
Page
of 18